ACE/AACE consensus conference on the implementation of outpatient management of diabetes mellitus: Consensus conference recommendations

Endocrine Practice

Volumn 12, Issue SUPPL. 1, 2006, Pages 6-12

  Lebovitz, Harold E ^a   Austin, Mary M ^a   Blonde, Lawrence ^a   Davidson, Jaime A ^a   Del Prato, Stefano ^a   Gavin III, James R ^a   Handelsman, Yehuda ^a   Jellinger, Paul S ^a   Levy, Philip ^a   Riddle, Matthew C ^a   Roberts, Victor L ^a   Siminerio, Linda M ^a  

^a ACE/AACE Diabetes Recommendations Implementations Writing Committee ^*

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; HEMOGLOBIN A1C; METFORMIN; TETRAHYDROLIPSTATIN; TROGLITAZONE; GLYCOSYLATED HEMOGLOBIN;

CLINICAL TRIAL; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DISEASE DURATION; GLYCEMIC CONTROL; HUMAN; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT CARE; PRACTICE GUIDELINE; PREVALENCE; SELF CARE; ADULT; AMBULATORY CARE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; INFORMATION SYSTEM; INTERNET; RISK FACTOR;

ADULT; AMBULATORY CARE; BLOOD GLUCOSE; DIABETES COMPLICATIONS; DIABETES MELLITUS; GLUCOSE INTOLERANCE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFORMATION SYSTEMS; INSULIN RESISTANCE; INTERNET; RISK FACTORS;

EID: 33646581374     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/ep.12.s1.6     Document Type: Conference Paper

References (35)

1. Centers for Disease Control and Prevention. Diabetes Fact Sheet. Available at: http://www.cdc.gov/diabetes/pubs/factsheet.htm. Accessed for verification December 13, 2005.
2. Hogan P, Dall T, Nikolov P (American Diabetes Association). Economic costs of diabetes in the US in 2002. Diabetes Care. 2003;26:917-932.
3. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
4. Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract. 1995; 28:103-117.
5. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) [erratum in Lancet. 1999;354:602]. Lancet. 1998;352:837-853.
6. Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321:405-412.
7. Khaw KT, Wareham N, Luben R, et al. Glycated haemoglobin, diabetes, and mortality in men in the Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk). BMJ. 2001;322:15-18.
8. Koro CE, Bowlin SJ, Bourgeois N, Fedder DO. Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report. Diabetes Care. 2004;27:17-20.
9. Narayan KM, Gregg EW, Engelgau MM, et al. Translation research for chronic disease: the case of diabetes. Diabetes Care. 2000;23:1794-1798.
10. Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004;291:335-342.
11. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events: a metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care. 1999;22:233-240.
12. DECODE Study Group, European Diabetes Epidemiology Group. Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases? Diabetes Care. 2003;26:688-696.
13. Writing Team for the Diabetes Control and Complications Trial/ Epidemiology of Diabetes Interventions and Complications Research Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA. 2002;287:2563-2569.
14. Knowler WC, Barrett-Connor E, Fowler SE, et al (Diabetes Prevention Program Research Group). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403.
15. Tuomilehto J, Lindstrom J, Eriksson JG, et al (Finnish Diabetes Prevention Study Group). Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343-1350.
16. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M (STOP-NIDDM Trial Research Group). Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet. 2002;359:2072-2077.
17. Wolford JK, Yeatts KA, Dhanjal SK, et al. Sequence variation in PPARG may underlie differential response to troglitazone. Diabetes. 2005;54:3319-3325.
18. Torgerson JS, Hauptman J, Boldrin MN, Sjostrom L. XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients [erratum in Diabetes Care. 2004;27:856]. Diabetes Care. 2004;27:155-161.
19. The American Association of Clinical Endocrinologists medical guidelines for the management of diabetes mellitus: the AACE system of intensive diabetes self-management - 2002 update. Endocr Pract. 2002;8(Suppl 1):40-82.
20. Monnier L, Lapinski H, Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c). Diabetes Care. 2003;26:881-885.
21. Hanefeld M, Koehler C, Schaper F, Fuecker K, Henkel E, Temelkova-Kurktschiev T. Postprandial plasma glucose is an independent risk factor for increased carotid intima-media thickness in non-diabetic individuals. Atherosclerosis. 1999;144:229-235.
22. Esposito K, Giugliano D, Nappo F, Marfella R (Campanian Postprandial Hyperglycemia Study Group). Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus. Circulation. 2004;110:214-219.
23. Hanefeld M, Chiasson JL, Koehler C, Henkel E, Schaper F, Temelkova-Kurktschiev T. Acarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose tolerance. Stroke. 2004;35:1073-1078.
24. Strowig SM, Aviles-Santa ML, Raskin P. Improved glycemic control without weight gain using triple therapy in type 2 diabetes. Diabetes Care. 2004;27:1577-1583.
25. Riddle MC, Rosenstock J, Gerich J (Insulin Glargine 4002 Study Investigators). The Treat-to-Target Trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care. 2003;26:3080-3086.
26. Genuth S. Insights from the Diabetes Control and Complications Trial/ Epidemiology of Diabetes Interventions and Complications Study on the use of intensive glycemic treatment to reduce the risk of complications of type 1 diabetes. Endocr Pract. 2006;12(Suppl 1):34-41.
27. Mensing C, Boucher J, Cypress M, et al (Task Force to Review and Revise the National Standards for Diabetes Self-Management Education Programs). National standards for diabetes self-management education. Diabetes Care. 2000;23:682-689.
28. Mulcahy K, Peeples M, Tomky D, Weaver T. National Diabetes Education Outcomes System: application to practice. Diabetes Educ. 2000;26:957-964.
29. Wagner EH, Austin BT, Von Korff M. Improving outcomes in chronic illness. Manag Care Q. 1996;4:12-25.
30. Rickheim PL, Weaver TW, Flader JL, Kendall DM. Assessment of group versus individual diabetes education: a randomized study. Diabetes Care. 2002;25:269-274.
31. Siminerio L, Zgibor J, Solano FX Jr. Implementing the chronic care model for improvements in diabetes practice and outcomes in primary care: the University of Pittsburgh Medical Center experience. Clin Diabetes. 2004;22:54-58.
32. Siminerio LM, Piatt G, Zgibor JC. Implementing the chronic care model for improvements in diabetes care and education in a rural primary care practice. Diabetes Educ. 2005;31:225-234.
33. Boucher JL, Pronk NP, Gehling EM. Telephone-based lifestyle counseling. Diabetes Spectrum. 2000;13:190-192.
34. McKay HG, King D, Eakin EG, Seeley JR, Glasgow RE. The diabetes network Internet-based physical activity intervention: a randomized pilot study. Diabetes Care. 2001;24:1328-1334.
35. Glasgow RE, Toobert DJ, Hampson SE. Effects of a brief office-based intervention to facilitate diabetes dietary self-management. Diabetes Care. 1996;19:835-842.